Helicobacter pylori and dementia. Which consistency for an association?

Panminerva Medica

Volumn 49, Issue 4, 2007, Pages 227-230

  Berrutti, M ^a   Pellicano, R ^a,c   Fagoonee, S ^b   Saracco, G ^a   Rizzetto, M ^a  

^a MOLINETTE HOSPITAL   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

^c Ambulatori di Gastro Epatologia   (Italy)

Author keywords

Alzheimer disease; Dementia; Epidemiology; Gastrointestinal diseases; Helicobacter pylori; Neurodegenerative diseases; Psychomotor disorders; Research, physiopathology

Indexed keywords

LEVODOPA;

ABSORPTION; ANIMAL; BIOLOGICAL MODEL; DEMENTIA; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; MEDLINE; METABOLISM; PATHOGENICITY; REVIEW;

ABSORPTION; ANIMALS; DEMENTIA; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; LEVODOPA; MEDLINE; MODELS, BIOLOGICAL;

EID: 38849152946     PISSN: 00310808     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (32)

1. Mladenova I, Durazzo M, Pellicano R. Transmission of Helicobacter pylori: are there evidences for a fecal-oral route? Minerva Med 2006;97:15-8.
2. De Martel C, Parsonnet J. Helicobacter pylori infection and gender: a meta-analysis of population-based prevalence surveys. Dig Dis Sci 2006;51:2292-301.
3. Testino G. Gastric precancerous changes: carcinogenesis, clinical behaviour immunophenotype study and surveillance. Panminerva Med 2006;48:109-18.
4. Pellicano R, Smedile A, Saracco G, Rizzetto M. Stem cells and Helicobacter-induced gastric cancer: where do we stand at the end of 2006. Panminerva Med 2006;48:175-9.
5. Pellicano R, Smedile A, Ponzetto A, Berrutti M, Astegiano M, Saracco G et al. How accurate is the culture of Helicobacter pylori in a clinical setting? An appraisal. Panminerva Med 2005;47:191-4.
6. Repici A, Pellicano R, Astegiano M, Saracco G, De Angelis C, Debernardi W et al. Invasive diagnosis of Helicobacter pylori infection in the 2006 clinical practice. Minerva Med 2006;97:25-9.
7. Pellicano R, Astegiano M, Smedile A, Bonardi R, Morgando A, Repici A et al. Non-invasive diagnosis of Helicobacter pylori infection in the 2006 clinical practice. Minerva Med 2006;97:19-24.
8. Avenaud P, Marais A, Monteiro L, Lebail B, Bioulac P, Balabaud C et al. Detection of Helicobacter spp in the liver of patients with and without primary liver carcinoma. Cancer 2000;89:1431-9.
9. Franceschi F, Roccarina D, Gasbarrini A. Extragastric manifestations of Helicobacter pylori infection. Minerva Med 2006;97:39-45.
10. Pellicano R, Peyre S, Astegiano M, Oliaro E, Fagoonee S, Rizzetto M. Updated review (2006) on Helicobacter pylori as a potential target for the therapy of ischemic heart disease. Panminerva Med 2006;48:241-6.
11. Danesh J, Gasbarrini A, Cremonini F, Gasbarrini G. Helicobacter pylori infection and extradigestive diseases. Curr Opin Gastroenterol 2001;16(S1):52-5.
12. Malaguarnera M, Bella R, Alagona G, Ferri R, Carnemolla A, Pennisi G. Helicobacter pylori and Alzheimer's disease: a possible link. Eur J Intern Med 2004;15:381-6.
13. Aben I, Verhey F. Depression after a cerebrovascular accident. The importance of the integration of neurobiological and psychosocial pathogenic models. Panminerva Med 2006;48:49-57.
14. th Edition. London: Edward Arnold Publishers Ltd; 2006. p. 355-67.
15. Rondanelli M, Sarra S, Antoniello N, Mansi V, Govoni S, Falvo F et al. No effect of atypical antipsychotic drugs on weight gain and risk of developing type II diabetes or lipid abnormalities among nursing home elderly patients with Alzheimer's disease. Minerva Med 2006;97:147-51.
16. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ et al. Assessing the quality of reports of randomized clinical trials: Is blinding necessary? Control Clin Trials 1996;17:1-12.
17. Kountouras J, Tsolaki M, Boziki M, Gavalas E, Zavos C, Stergiopoulos C et al. Association between Helicobacterpylori infection and mild cognitive impairment. Eur J Neurol 2007;14:976-82.
18. Kountouras J, Tsolaki M, Gavalas E, Bozik M, Zavos C, Karatzoglou P et al. Relationship between Helicobacter pylori infection and Alzheimer disease. Neurology 2006;66:938-40.
19. Sipos G, Altdorfer K, Pongor E, Chen LP, Fehér E. Neuroimmune link in the mucosa of chronic gastritic with Helicobacter pylori infection. Dig Dis Sci 2006;51:1810-7.
20. Kountouras J, Deretzib G, Zavosa C, Karatzoglou P, Touloumis L, Nicolaides T et al. Association between Helicobacter pylori infection and acute inflammatory demyelinating polyradiculoneuropathy. Eur J Neurol 2005;12:139-43.
21. Schulz JD, Hawkes EL, Shaw CA. Cycad toxins, Helicobacter pylori and parkinsonism: cholesterol glucosides as the common denomenator. Med Hypotheses 2006;66:1222-6.
22. Evrengul H, Tanriverdi H, Kuru O, Enli Y, Yuksel D, Kilic A et al. Elevated homocysteine levels in patients with slow coronary flow: relationship with Helicobacter pylori infection. Helicobacter 2007;12:298-305.
23. Kountouras J, Gavalas E, Zavos C, Stergiopoulos C, Chatzopoulos D, Kapetanakis N et al. Alzheimer's disease and Helicobacter pylori infection: defective immune regulation and apoptosis as proposed common links. Medical Hypotheses 2007;68:378-88.
24. Larsson PT, Hallerstam S, Rosfors S, Wallen NH. Circulating markers of inflammation are related to carotid artery atherosclerosis. Int Angiol 2005;24:43-51.
25. Piro M, Giubilato G, Pinnelli M, Giordano Sciacca P, Biasucci LM. Endothelium and inflammation. Panminerva Med 2005;47:75-80.
26. Avanzas P, Arroyo-Espliguero R, Garcia-Moll X, Kaski JC. Inflammation biomarkers of coronary atheromatous plaque vulnerability. Panminerva Med 2005;47:81-91.
27. Pierantozzi M, Pietroiusti A, Galante A, Sancesario G, Lunardi G, Fedele E et al. Helicobacter pylori-induced reduction of acute levodopa absorption in Parkinson's disease patients. Ann Neurol 2001;50:686-7.
28. Schwab RS. Symptomatology and medical treatment of Parkinson's disease. Int J Neurol 1961;2:61.
29. Strang RR. The association of gastro-duodenal ulceration with Parkinson's disease. Med J Austr 1965;52:842-3.
30. Glavin GB. Activity of selective dopamine DA1 and DA2agonists and antagonists on experimental gastric lesions and gastric acid secretion. J Pharmacol Exp Ther 1989;251:726-30.
31. Szabo S. Dopamine disorder in duodenal ulceration. Lancet 1979;2:880-2.
32. Coggon DIW, Martyn CN. Time and chance: the stochastic nature of disease causation. Lancet 2005;365:1434-7.